<DOC>
	<DOCNO>NCT00877253</DOCNO>
	<brief_summary>The purpose study determine maximum tolerate dose Genexol®-PM plus Carboplatin evaluate efficacy safety Genexol®-PM plus Carboplatin regimen subject advance ovarian cancer .</brief_summary>
	<brief_title>Determine MTD , Evaluate Efficacy Safety Genexol®-PM Plus Carboplatin With Advanced Ovarian Cancer</brief_title>
	<detailed_description>This phase I trial determine maximum tolerate dose recommended phase II dose combination therapy Genexol®-PM Carboplatin evaluate efficacy safety Genexol®-PM administer Carboplatin subject advance ovarian cancer debulking surgery .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Women ≥ 18 year old . Signed informed consent inclusion . Subjects histologically cytologically confirm advanced epithelial ovarian cancer . ( FIGO IIIBIV ) Subjects measurable disease RECIST debulking surgery . ECOG performance status 0 , 1 , 2 . Estimated life expectancy 6 month Subjects clinically acceptable function blood , kidney liver screen visit Hb ≥ 10g/dl ANC ≥ 1.5×10^9/L Platelet Count ≥ 100×10^9/L Serum total bilirubin ≤ 1.5×ULN Serum AST ALT ≤ 2.5×ULN Serum ALP ≤ 2.5×ULN Serum creatinine ≤ 1.5×ULN Subjects receive chemotherapy ovarian cancer debulking surgery . Subjects history radiotherapy pelvis abdominal cavity Subjects receive immunotherapy hormonal therapy ovarian cancer Subjects malignancy within past 5 year Subjects major surgery debulking surgery within 2 week prior screening/baseline visit Subjects history metastasis currently metastasis central nervous system ( CNS ) Subjects preexist sensory motor neuropathy grade ≥ 1 base NCI CTCAE V3.0 Subjects serious medical condition Uncontrolled severe cardiovascular disease ( Ischemic heart disease , myocardial infarction within last 6 month , congestive heart failure ) Uncontrollable infection Previous allergic reaction connection paclitaxel carboplatin Subjects participate another clinical trial within last 4 week inclusion</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>